Atlas Trials

A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome

Clinical trial NCT02217007 · WITHDRAWN

Trial details

NCT number
NCT02217007
Sponsor
Synchroneuron Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Tourette Syndrome
Start date
2015-04-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.